IP Library Granted Patent US 9,717,765
Granted Patent B2
US 9,717,765 · App. 15/349,371 · Granted Aug 1, 2017

Method of identifying a biologically-active composition from a biofilm

Inventors: Eva A. Berkes (Sarasota, FL); Nicholas T. Monsul (Sarasota, FL); Frederick T. Boehm (Sarasota, FL)
Assignee: QUORUM INNOVATIONS, LLC
A61K35/74A01N63/02A61K8/67A61K8/97A61K8/981A61K8/988A61K8/99A61K9/007A61K9/0043A61K9/0046A61K9/0048A61K35/644A61K35/744A61K35/747A61K39/092A61K45/06A61Q11/00A61Q17/005A61Q19/10C12N1/20C12Q1/04A61K36/61A61K2300/00A61K2800/78A61K2800/782G01N2333/315G01N2333/335
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,717,765
App. No.
15/349,371
Granted
Aug 1, 2017
Kind
B2
Abstract

The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin D3.

Claims (20)

1. A method for identifying and selecting a biologically-active composition, wherein said method comprises: (1) growing a microbial biofilm within a reactor vessel, wherein the biofilm is contacted with a biological growth medium within said reactor vessel; (2) harvesting said biofilm by removing the biofilm from the reactor vessel thereby obtaining a fraction comprising biofilm cellular mass; (3) testing said fraction that comprises biofilm cellular mass for biological activity; and (4) selecting, as the biologically-active composition, a fraction that is found to have biological activity.

2. A method for preparing a biologically-active composition, wherein said method comprises: (1) growing a microbial biofilm within a reactor vessel, wherein the biofilm is contacted with a biological growth medium within said reactor vessel; (2) harvesting said biofilm by removing the biofilm from the reactor vessel thereby obtaining a fraction comprising biologically-active biofilm cellular mass; and (3) combining said fraction with an appropriate carrier to form said biologically-active composition.

3. The method, according to claim 2 , wherein the biological activity is anti-microbial activity or anti-inflammatory activity.

4. The method, according to claim 2 , wherein the microbial biofilm is of a probiotic microbe selected from the group consisting of Bacteroides, Bifidobacterium , and Lactobacillus .

5. The method, according to claim 4 , wherein the microbe is a Lactobacillus .

6. The method, according to claim 2 , comprising a step of separating supernatant from the biofilm cellular mass by centrifugation or filtration.

7. The method, according to claim 1 , wherein the biological activity is anti-microbial activity or anti-inflammatory activity.

8. The method, according to claim 1 , wherein the biofilm is of a probiotic microbe.

9. The method, according to claim 1 , wherein the microbe is selected from the group consisting of Bacteroides, Bifidobacterium , and Lactobacillus .

10. The method, according to claim 9 , wherein the microbe is a Lactobacillus .

11. The method, according to claim 1 , comprising a step of separating supernatant from the biofilm cellular mass by centrifugation or filtration.

12. The method, according to claim 1 , wherein the biofilm is grown from a biological sample obtained from a human.

13. The method, according to claim 7 , wherein the biological activity is anti-microbial activity.

14. The method, according to claim 7 , wherein the biological activity is anti-inflammatory activity.

15. The method, according to claim 2 , wherein the biological activity is anti-microbial activity.

16. The method, according to claim 2 , wherein the biological activity is anti-inflammatory activity.

17. The method, according to claim 2 , wherein the composition comprises alcohol.

18. The method, according to claim 2 , wherein the composition comprises a food product.

19. The method, according to claim 2 , which is a cosmetic composition and the carrier is suitable for cosmetic use.

20. The method, according to claim 3 , wherein the carrier is appropriate for topical administration.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2025
From: QUORUM INNOVATIONS, LLC
To: QUORUM INNOVATIONS, INC.
Reel/Frame 072547/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2016
From: BERKES, EVA A.; MONSUL, NICHOLAS T.; BOEHM, FREDERICK T.
To: QUORUM INNOVATIONS, LLC
Reel/Frame 040698/0949 →
Continuity (3)
Continuation 13503325
Provisional Application 61447735 · Mar 1, 2011
Related Publication 20170056454A1 · Mar 2, 2017